HCA Healthcare, Inc. $HCA Shares Sold by Eagle Rock Investment Company LLC

Eagle Rock Investment Company LLC lessened its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 84.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,755 shares of the company’s stock after selling 9,470 shares during the quarter. Eagle Rock Investment Company LLC’s holdings in HCA Healthcare were worth $749,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of HCA. Sunbelt Securities Inc. lifted its position in HCA Healthcare by 171.7% in the first quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock valued at $2,954,000 after purchasing an additional 3,945 shares during the period. Sei Investments Co. increased its position in HCA Healthcare by 27.5% during the 1st quarter. Sei Investments Co. now owns 467,796 shares of the company’s stock worth $221,380,000 after purchasing an additional 100,764 shares during the period. SEB Asset Management AB purchased a new position in shares of HCA Healthcare during the 1st quarter worth approximately $75,534,000. OP Asset Management Ltd acquired a new stake in shares of HCA Healthcare in the 1st quarter valued at approximately $12,883,000. Finally, Darsana Capital Partners LP lifted its holdings in shares of HCA Healthcare by 46.7% in the 2nd quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock valued at $428,879,000 after buying an additional 350,000 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $459.14 on Thursday. The firm has a market capitalization of $99.40 billion, a price-to-earnings ratio of 15.37, a price-to-earnings-growth ratio of 1.57 and a beta of 1.10. The business’s 50 day simple moving average is $429.18 and its 200-day simple moving average is $418.65. HCA Healthcare, Inc. has a 12 month low of $353.99 and a 12 month high of $556.52.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating the consensus estimate of $7.56 by $0.03. The firm had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%. HCA Healthcare’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period last year, the business posted $6.84 EPS. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 29.45 earnings per share for the current year.

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: TD Cowen raised its price target to $460 while maintaining its view on HCA, signaling continued confidence in the hospital operator’s outlook. However, the revised target implies limited near-term upside at current levels. TD Cowen raises HCA Healthcare price target
• Positive Sentiment: HCA opened a new $22 million freestanding emergency department in Florida, expanding its care network and potentially supporting long-term admissions and revenue growth. The financial impact is likely to be gradual. HCA opens new Florida freestanding emergency department
• Neutral Sentiment: The CEO of HCA Florida Capital Hospital, Dale Neely, is stepping down. The departure creates some management uncertainty, although no operational disruption or broader leadership change was reported. HCA Florida hospital CEO to exit
• Negative Sentiment: HCA is disputing North Carolina’s authority to enforce provisions of its 2019 Mission Health acquisition agreement. The legal dispute could increase regulatory scrutiny and create potential compliance costs, penalties or restrictions involving the Mission system. HCA disputes state authority over Mission deal
• Negative Sentiment: Pomerantz LLP announced an investigation into potential claims on behalf of HCA investors. Although such law-firm announcements do not establish wrongdoing, they add headline and litigation risk and may weigh on sentiment. Pomerantz investor investigation
• Negative Sentiment: Analysts expect a decline in HCA’s upcoming earnings, and Zacks said the company lacks the typical factors supporting a likely earnings beat. This raises caution ahead of the earnings report and may be the most direct near-term pressure on the stock. HCA earnings expectations

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on HCA. Truist Financial dropped their price objective on HCA Healthcare from $535.00 to $495.00 and set a “buy” rating on the stock in a report on Monday, July 27th. The Goldman Sachs Group reduced their target price on HCA Healthcare from $558.00 to $485.00 and set a “buy” rating for the company in a report on Tuesday, July 28th. Barclays decreased their target price on shares of HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating on the stock in a research report on Monday, July 27th. Raymond James Financial set a $528.00 price target on shares of HCA Healthcare in a research note on Tuesday, July 7th. Finally, Jefferies Financial Group set a $450.00 price objective on shares of HCA Healthcare in a research note on Tuesday, July 14th. Sixteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $467.61.

HCA Healthcare Profile

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.